USUBJID,AE_TERM,BODY_SYSTEM,SEVERITY,DRUG_RELATIONSHIP,SERIOUS,OUTCOME,DROPOUT_LABEL,ARM
01-701-1015,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1015,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1015,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1023,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-701-1023,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-701-1023,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-701-1023,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-701-1028,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1028,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1034,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1034,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1047,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-701-1047,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-701-1047,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-701-1047,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-701-1097,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1097,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1097,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1097,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1097,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1097,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1097,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1097,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1097,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1097,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1111,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1111,CELLULITIS,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1111,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1111,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-701-1111,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1111,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1111,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1111,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-701-1115,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1115,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1115,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1115,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1115,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-701-1115,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1115,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1115,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1115,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1118,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1130,EYE ALLERGY,EYE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1130,EYE PRURITUS,EYE DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1130,EYE SWELLING,EYE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1130,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1130,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1130,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1130,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1130,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1133,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1133,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1133,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1133,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1146,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1146,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1146,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1146,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1146,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1146,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1146,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1146,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1146,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1146,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1146,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1148,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1148,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1148,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1148,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1148,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1148,DYSPEPSIA,GASTROINTESTINAL DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1148,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1148,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1148,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1148,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1153,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1153,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1180,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1180,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1180,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1180,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1180,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1180,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1180,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1180,VOMITING,GASTROINTESTINAL DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1180,VOMITING,GASTROINTESTINAL DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1181,AGITATION,PSYCHIATRIC DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1188,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1188,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1188,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1188,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1188,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1188,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1188,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1188,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1192,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,NASAL MUCOSA BIOPSY,INVESTIGATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,PNEUMONIA,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,PNEUMONIA,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1192,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1203,EYE LASER SURGERY,SURGICAL AND MEDICAL PROCEDURES,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1211,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1211,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1211,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1211,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1211,INCONTINENCE,RENAL AND URINARY DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1211,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-701-1211,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1211,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1211,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,NONE,N,FATAL,Dropout,Xanomeline Low Dose
01-701-1239,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1239,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1239,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1239,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1239,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1239,HORDEOLUM,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1239,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1239,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1239,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1239,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1275,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,PAROSMIA,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,PAROSMIA,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1275,VOMITING,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1287,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1287,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1287,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1287,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1287,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1294,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1294,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1294,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-701-1294,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1294,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1294,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1302,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,LISTLESS,PSYCHIATRIC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,RHINITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1302,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1317,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1317,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1317,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1317,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1317,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1317,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1317,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1317,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1317,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1324,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1324,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1324,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1324,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-701-1341,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1341,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1341,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-701-1341,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-701-1341,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-701-1360,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1360,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1360,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1363,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1363,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1363,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1363,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1363,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1363,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1383,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1383,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1383,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1383,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1383,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1383,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1383,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1383,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-701-1383,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1383,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1383,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1383,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-701-1387,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-701-1387,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-701-1392,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1392,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1415,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1415,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1415,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1415,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1415,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-701-1415,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-701-1442,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-701-1444,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1444,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1444,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1444,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1444,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1444,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-701-1444,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-701-1444,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-702-1082,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-702-1082,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-702-1082,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-702-1082,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-702-1082,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-702-1082,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-702-1082,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-702-1082,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-702-1082,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-702-1082,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-703-1042,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-703-1042,INSOMNIA,PSYCHIATRIC DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-703-1076,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1076,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1076,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1076,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1076,BIOPSY PROSTATE,INVESTIGATIONS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-703-1076,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1076,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1086,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1086,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1086,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1086,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-703-1086,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1086,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-703-1100,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1100,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1100,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-703-1100,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-703-1100,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1100,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-703-1100,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1100,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-703-1100,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-703-1119,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1119,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1119,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1119,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1175,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,SEVERE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-703-1182,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1182,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1182,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1182,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-703-1210,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1210,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1210,DISORIENTATION,PSYCHIATRIC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1258,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1258,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1258,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-703-1258,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1258,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1258,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1258,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-703-1295,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1299,GLAUCOMA,EYE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1299,HYPOTENSION,VASCULAR DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1299,HYPOTENSION,VASCULAR DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1299,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1299,TACHYCARDIA,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1299,TACHYCARDIA,CARDIAC DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1299,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-703-1299,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-703-1335,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1335,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-703-1403,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-703-1403,DIARRHOEA,GASTROINTESTINAL DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-703-1403,VOMITING,GASTROINTESTINAL DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-703-1403,WEIGHT DECREASED,INVESTIGATIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-703-1403,WEIGHT DECREASED,INVESTIGATIONS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-703-1439,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-703-1439,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-704-1008,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1008,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1008,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,SEVERE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1009,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1009,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1009,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1009,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-704-1009,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-704-1009,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1010,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-704-1010,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-704-1010,CYSTITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-704-1010,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-704-1010,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-704-1010,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-704-1010,VOMITING,GASTROINTESTINAL DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-704-1017,CARDIAC DISORDER,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1017,INFLUENZA,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1017,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1017,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1017,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1017,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1017,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1017,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1025,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1025,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-704-1025,PALPITATIONS,CARDIAC DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-704-1025,VERTIGO,EAR AND LABYRINTH DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-704-1025,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1025,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-704-1065,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1065,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1065,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1065,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1065,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1065,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1065,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1065,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1065,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1065,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1074,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1074,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1093,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1093,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1093,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1093,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1114,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-704-1114,INFLUENZA,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-704-1114,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1114,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1114,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1120,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1120,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-704-1120,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1120,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1120,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1120,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1135,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-704-1135,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-704-1164,INFLUENZA,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-704-1164,INFLUENZA,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-704-1164,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-704-1218,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-704-1241,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1241,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,ATRIAL FLUTTER,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,ATRIAL FLUTTER,CARDIAC DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1266,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1323,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1323,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1323,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1323,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-704-1325,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1325,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-704-1332,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1332,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1332,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1332,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1332,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-704-1332,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-704-1351,FLATULENCE,GASTROINTESTINAL DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-704-1351,FLATULENCE,GASTROINTESTINAL DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-704-1351,POLLAKIURIA,RENAL AND URINARY DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-704-1351,POLLAKIURIA,RENAL AND URINARY DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-704-1388,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-704-1435,PARKINSON'S DISEASE,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-704-1445,COMPLETED SUICIDE,PSYCHIATRIC DISORDERS,SEVERE,NONE,N,FATAL,Dropout,Placebo
01-705-1031,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-705-1059,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-705-1186,HYPERBILIRUBINAEMIA,HEPATOBILIARY DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-705-1199,DYSPEPSIA,GASTROINTESTINAL DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-705-1199,DYSPEPSIA,GASTROINTESTINAL DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-705-1280,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-705-1281,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-705-1281,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-705-1281,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-705-1292,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-705-1292,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-705-1303,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-705-1303,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-705-1303,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-705-1303,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-705-1310,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-705-1310,WOUND HAEMORRHAGE,VASCULAR DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-705-1349,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-705-1349,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-705-1349,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-705-1349,VOMITING,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-705-1393,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-705-1393,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",SEVERE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-705-1393,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-705-1393,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-705-1431,ANXIETY,PSYCHIATRIC DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-705-1431,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-706-1041,ANXIETY,PSYCHIATRIC DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-706-1041,ANXIETY,PSYCHIATRIC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-706-1041,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-706-1041,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-706-1041,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-706-1041,IRRITABILITY,PSYCHIATRIC DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-706-1041,IRRITABILITY,PSYCHIATRIC DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-706-1041,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-706-1041,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-706-1049,SYNCOPE,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-706-1049,SYNCOPE,NERVOUS SYSTEM DISORDERS,SEVERE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-706-1384,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-706-1384,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-706-1384,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-706-1384,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-706-1384,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-706-1384,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-706-1384,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-706-1384,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-706-1384,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-706-1384,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-707-1206,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-707-1206,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-707-1206,CONJUNCTIVITIS,EYE DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-707-1206,CONJUNCTIVITIS,EYE DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-707-1206,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-707-1206,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-707-1206,SINUS ARRHYTHMIA,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-707-1206,SINUS ARRHYTHMIA,CARDIAC DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1019,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1019,HEADACHE,NERVOUS SYSTEM DISORDERS,SEVERE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1019,STUPOR,NERVOUS SYSTEM DISORDERS,SEVERE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1019,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,SEVERE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1019,VISION BLURRED,EYE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1032,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1084,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-708-1084,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-708-1084,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-708-1084,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-708-1084,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-708-1084,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-708-1087,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1087,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1087,HEART RATE IRREGULAR,INVESTIGATIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1087,HEART RATE IRREGULAR,INVESTIGATIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1087,HEART RATE IRREGULAR,INVESTIGATIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1087,HEART RATE IRREGULAR,INVESTIGATIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1158,AGITATION,PSYCHIATRIC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-708-1158,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-708-1178,ALCOHOL USE,SOCIAL CIRCUMSTANCES,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1178,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1178,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1178,ATRIAL FIBRILLATION,CARDIAC DISORDERS,SEVERE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1178,CYSTITIS,INFECTIONS AND INFESTATIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1178,DIZZINESS,NERVOUS SYSTEM DISORDERS,SEVERE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1178,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1178,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1178,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1213,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1213,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1216,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1216,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1216,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1216,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1253,CONJUNCTIVITIS,EYE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1253,CONJUNCTIVITIS,EYE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1253,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1253,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1253,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1253,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1253,HEART RATE INCREASED,INVESTIGATIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1253,HEART RATE INCREASED,INVESTIGATIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1272,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1272,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-708-1272,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1272,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1272,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-708-1272,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1272,HOT FLUSH,VASCULAR DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1272,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,SEVERE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1272,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-708-1272,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1272,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-708-1272,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1286,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1286,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1286,CONSTIPATION,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1286,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1296,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1296,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1296,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1296,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1296,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1296,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1296,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-708-1297,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-708-1297,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-708-1297,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-708-1316,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1316,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-708-1336,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-708-1336,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-708-1336,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-708-1336,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-708-1336,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-708-1336,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-708-1336,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-708-1347,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1347,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1347,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1347,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1347,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1347,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1347,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1347,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-708-1348,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-708-1348,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-708-1348,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-708-1353,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-708-1353,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1353,HYPOTENSION,VASCULAR DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1372,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-708-1406,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-708-1406,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-708-1428,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-708-1428,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1428,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-708-1428,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1428,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-708-1428,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-708-1428,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1007,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1007,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1007,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1007,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1020,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-709-1020,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-709-1020,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-709-1020,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-709-1029,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1029,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1029,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1029,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1029,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1029,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1029,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1029,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1029,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1029,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1029,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1029,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1029,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1029,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1029,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1029,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1081,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1081,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1088,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-709-1088,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-709-1099,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1099,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1099,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1099,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1099,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1099,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1099,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1099,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1102,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1102,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1102,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1102,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1102,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1102,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1168,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-709-1168,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-709-1168,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-709-1168,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-709-1168,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-709-1168,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-709-1217,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1217,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1217,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1217,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1217,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1217,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1217,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1217,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1217,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1217,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1217,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1238,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-709-1238,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-709-1238,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-709-1238,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-709-1238,DIARRHOEA,GASTROINTESTINAL DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-709-1238,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-709-1238,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-709-1238,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-709-1259,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-709-1259,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,SEVERE,NONE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-709-1259,BLOOD URINE PRESENT,INVESTIGATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-709-1259,CYSTOSCOPY,INVESTIGATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-709-1259,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-709-1259,HYPOTENSION,VASCULAR DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-709-1259,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-709-1259,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-709-1259,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-709-1259,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-709-1259,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-709-1285,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1285,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1285,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1285,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-709-1285,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1285,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-709-1301,DIABETES MELLITUS,METABOLISM AND NUTRITION DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-709-1306,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-709-1306,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-709-1306,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-709-1306,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-709-1306,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-709-1306,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-709-1306,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-709-1306,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-709-1306,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-709-1309,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1309,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1309,BIOPSY,INVESTIGATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1309,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1309,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1309,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1309,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1309,NIGHTMARE,PSYCHIATRIC DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1309,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1309,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1309,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1309,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1309,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1309,VOMITING,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-709-1309,VOMITING,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-709-1312,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-709-1312,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-709-1326,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-709-1326,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-709-1326,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-709-1326,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-709-1326,SYNCOPE,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-709-1326,VOMITING,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-709-1329,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-709-1329,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-709-1339,BLOOD ALKALINE PHOSPHATASE INCREASED,INVESTIGATIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-709-1339,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-709-1424,SYNCOPE,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,Y,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1002,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1002,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1006,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1006,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-710-1006,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-710-1006,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1006,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-710-1006,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-710-1006,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1006,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1006,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1006,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-710-1006,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1006,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-710-1021,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1021,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-710-1021,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1027,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1027,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-710-1027,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1027,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-710-1045,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1045,VOMITING,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1053,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1053,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1053,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1053,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1060,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-710-1060,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-710-1060,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-710-1060,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-710-1060,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-710-1060,INSOMNIA,PSYCHIATRIC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1060,INSOMNIA,PSYCHIATRIC DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-710-1060,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-710-1070,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-710-1070,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,SEVERE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1070,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SEVERE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1070,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-710-1070,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-710-1070,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-710-1077,AGITATION,PSYCHIATRIC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1077,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-710-1077,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,SEVERE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1077,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1077,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1083,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,SEVERE,POSSIBLE,N,FATAL,Dropout,Placebo
01-710-1137,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-710-1137,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-710-1137,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-710-1137,VERTIGO,EAR AND LABYRINTH DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-710-1142,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1142,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1142,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1142,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1142,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1154,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1154,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1166,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1166,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1166,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1166,SYNCOPE,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1166,SYNCOPE,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1183,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1183,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1187,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1235,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-710-1235,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-710-1235,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-710-1249,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1249,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-710-1249,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-710-1249,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1264,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1264,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1264,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1264,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1264,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1264,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1264,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1264,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-710-1264,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-710-1270,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1270,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1271,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1271,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-710-1271,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1271,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1271,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,SEVERE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1278,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-710-1278,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1278,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1278,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-710-1278,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1278,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1278,VOMITING,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-710-1300,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1300,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1300,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1300,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1314,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-710-1314,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1315,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-710-1315,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1315,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1315,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-710-1315,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1315,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-710-1315,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-710-1354,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1354,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1358,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1358,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1358,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1368,DELUSION,PSYCHIATRIC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1368,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SEVERE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1368,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SEVERE,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-710-1368,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-710-1385,ATRIAL FIBRILLATION,CARDIAC DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1385,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1385,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1385,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1385,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1385,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1385,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-710-1385,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-710-1408,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1408,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-710-1408,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-710-1408,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-711-1012,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-711-1012,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-711-1012,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-711-1012,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-711-1012,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-711-1012,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-711-1012,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-711-1036,EAR INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-711-1036,EAR INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-711-1036,GLOSSITIS,GASTROINTESTINAL DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-711-1036,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-711-1143,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,SEVERE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,TINNITUS,EAR AND LABYRINTH DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-711-1143,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-711-1433,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-711-1433,HYPERTENSION,VASCULAR DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-711-1433,HYPERTENSION,VASCULAR DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-713-1043,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-713-1043,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-713-1043,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-713-1043,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-713-1043,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-713-1043,VOMITING,GASTROINTESTINAL DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-713-1043,VOMITING,GASTROINTESTINAL DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-713-1073,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-713-1141,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-713-1141,DELIRIUM,PSYCHIATRIC DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-713-1141,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-713-1141,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-713-1179,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1179,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1179,CERVICITIS,INFECTIONS AND INFESTATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1179,CERVICITIS,INFECTIONS AND INFESTATIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-713-1179,DYSPEPSIA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-713-1179,DYSPEPSIA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1179,DYSURIA,RENAL AND URINARY DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-713-1179,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-713-1179,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1179,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1179,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-713-1179,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1179,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-713-1179,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1179,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-713-1209,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-713-1209,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-713-1209,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-713-1209,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-713-1256,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1256,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-713-1269,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1269,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1269,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1269,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1269,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1269,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-713-1448,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-713-1448,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-713-1448,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-713-1448,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-714-1035,BRONCHITIS,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-714-1035,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-714-1035,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-714-1035,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-714-1035,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-714-1035,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-714-1035,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-714-1068,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-714-1068,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-714-1068,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-714-1068,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-714-1068,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-714-1068,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-714-1195,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-714-1195,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-714-1195,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-714-1195,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-714-1195,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-714-1195,DYSURIA,RENAL AND URINARY DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-714-1195,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-714-1195,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-714-1195,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-714-1288,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-714-1288,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-714-1288,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-714-1288,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-714-1288,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-714-1288,DIZZINESS,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-714-1288,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-714-1288,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-714-1288,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-714-1375,EAR PAIN,EAR AND LABYRINTH DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-714-1375,EAR PAIN,EAR AND LABYRINTH DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-714-1375,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-714-1375,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-714-1375,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-714-1375,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-714-1375,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-714-1375,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-714-1425,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-715-1107,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-715-1107,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-715-1107,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-715-1207,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-715-1319,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-715-1321,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-715-1321,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-715-1321,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-715-1321,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-715-1405,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-715-1405,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-715-1405,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-715-1405,PALPITATIONS,CARDIAC DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-715-1405,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-715-1405,SINUS BRADYCARDIA,CARDIAC DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-716-1024,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1024,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1024,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-716-1026,EAR INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-716-1026,EAR INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-716-1026,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1026,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1026,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-716-1026,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1026,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1044,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1044,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1044,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-716-1063,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1063,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1063,LETHARGY,NERVOUS SYSTEM DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1063,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1063,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-716-1063,RESTLESSNESS,PSYCHIATRIC DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1063,RESTLESSNESS,PSYCHIATRIC DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-716-1071,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-716-1071,HYPERSOMNIA,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-716-1071,SYNCOPE,NERVOUS SYSTEM DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-716-1094,ATRIAL FLUTTER,CARDIAC DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1094,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1094,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1103,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-716-1103,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-716-1103,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-716-1103,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-716-1103,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-716-1108,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1108,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1151,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1151,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1151,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-716-1151,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1157,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-716-1157,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-716-1157,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-716-1157,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-716-1160,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1160,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1167,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-716-1167,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-716-1167,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-716-1167,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-716-1167,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-716-1177,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1189,DELUSION,PSYCHIATRIC DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-716-1189,HALLUCINATION,PSYCHIATRIC DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-716-1189,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",SEVERE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-716-1189,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-716-1229,BLOOD CHOLESTEROL INCREASED,INVESTIGATIONS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-716-1229,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-716-1298,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1298,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-716-1298,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1298,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-716-1298,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1298,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-716-1308,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-716-1311,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,MODERATE,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-716-1311,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1311,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-716-1311,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-716-1364,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-716-1364,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-716-1373,COGNITIVE DISORDER,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-716-1373,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-716-1418,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-716-1418,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-716-1418,HEADACHE,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-716-1418,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-716-1418,HEADACHE,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-716-1418,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-716-1418,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-716-1418,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-716-1418,VISION BLURRED,EYE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-716-1418,VISION BLURRED,EYE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-716-1441,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-716-1447,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-716-1447,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-716-1447,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-716-1447,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-716-1447,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-717-1004,ANXIETY,PSYCHIATRIC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MODERATE,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,ENURESIS,RENAL AND URINARY DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,IRRITABILITY,PSYCHIATRIC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1004,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-717-1109,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-717-1109,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-717-1109,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-717-1109,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-717-1109,INSOMNIA,PSYCHIATRIC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-717-1109,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-717-1109,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-717-1109,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-717-1174,INSOMNIA,PSYCHIATRIC DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-717-1174,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-717-1174,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-717-1174,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SEVERE,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline High Dose
01-717-1174,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-717-1174,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline High Dose
01-717-1201,ALOPECIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-717-1201,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-717-1344,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Placebo
01-717-1344,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-717-1344,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-717-1344,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-717-1344,VOMITING,GASTROINTESTINAL DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Dropout,Placebo
01-717-1357,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-717-1357,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-717-1357,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-717-1357,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-717-1357,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-717-1357,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-717-1357,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-717-1357,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-717-1357,VOMITING,GASTROINTESTINAL DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-717-1446,ANXIETY,PSYCHIATRIC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1446,ANXIETY,PSYCHIATRIC DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-717-1446,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-717-1446,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1446,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1446,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-717-1446,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-717-1446,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-717-1446,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-718-1066,AGITATION,PSYCHIATRIC DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1066,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1066,SYNCOPE,NERVOUS SYSTEM DISORDERS,SEVERE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-718-1066,SYNCOPE,NERVOUS SYSTEM DISORDERS,SEVERE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1079,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1079,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SEVERE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1079,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1101,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-718-1101,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1101,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-718-1101,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-718-1101,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1101,VOMITING,GASTROINTESTINAL DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1139,DIARRHOEA,GASTROINTESTINAL DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1139,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1139,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1150,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1150,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1150,BRADYCARDIA,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1150,BRADYCARDIA,CARDIAC DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1150,BRADYCARDIA,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1150,BRADYCARDIA,CARDIAC DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1150,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1150,SINUS BRADYCARDIA,CARDIAC DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1150,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1150,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,MODERATE,NONE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1170,AGITATION,PSYCHIATRIC DISORDERS,SEVERE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1170,BODY TEMPERATURE INCREASED,INVESTIGATIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-718-1170,DIZZINESS,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-718-1170,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-718-1170,HYPERTENSION,VASCULAR DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-718-1170,SYNCOPE,NERVOUS SYSTEM DISORDERS,SEVERE,PROBABLE,Y,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-718-1250,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1250,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1250,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-718-1250,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1250,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1250,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-718-1250,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1250,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline Low Dose
01-718-1250,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-718-1250,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-718-1250,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",MILD,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline Low Dose
01-718-1254,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-718-1254,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-718-1254,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-718-1254,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-718-1254,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-718-1254,DYSPHAGIA,GASTROINTESTINAL DISORDERS,MODERATE,,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-718-1254,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,MODERATE,,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-718-1254,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Xanomeline Low Dose
01-718-1254,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Completed,Xanomeline Low Dose
01-718-1328,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1328,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1328,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-718-1328,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1355,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1355,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1355,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1355,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1355,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1355,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1355,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1355,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1355,HYPERTENSION,VASCULAR DISORDERS,MODERATE,REMOTE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1355,HYPERTENSION,VASCULAR DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1355,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1355,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Completed,Placebo
01-718-1355,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,MODERATE,NONE,N,NOT RECOVERED/NOT RESOLVED,Completed,Placebo
01-718-1371,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-718-1371,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-718-1371,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1371,"HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1371,NAUSEA,GASTROINTESTINAL DISORDERS,MILD,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1371,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,SEVERE,NONE,Y,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,AMNESIA,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,AMNESIA,NERVOUS SYSTEM DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MILD,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MODERATE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MILD,NONE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,LETHARGY,NERVOUS SYSTEM DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,REMOTE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,NAUSEA,GASTROINTESTINAL DISORDERS,SEVERE,PROBABLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,POSSIBLE,N,NOT RECOVERED/NOT RESOLVED,Dropout,Xanomeline High Dose
01-718-1427,NAUSEA,GASTROINTESTINAL DISORDERS,MODERATE,POSSIBLE,N,RECOVERED/RESOLVED,Dropout,Xanomeline High Dose
